Background: Intrauterine inflammation has been associated with preterm birth and with fetal inflammatory response affecting various organs including immature brain. Prenatal etiology has been defined in a majority of term infants with later neurologic sequela but only in a minority of very preterm infants. Risk factors of cerebral white matter damage (WMD) may differ between term and preterm infants.
SUCCESSFUL TREATMENT OF PULMONARY HYPERTENSION WITH SIL-DENAFIL IN A NEONATE WITH SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA
Z KECSKES 1, 3 , A KENT 1, 3 , G REYNOLDS 2,3 1
DEPT OF NEONATOLOGY, THE CANBERRA HOS-PITAL , 2 DEPT OF PAEDIATRICS, THE CANBERRA HOSPITAL, 3 AUSTRALIAN NATIONAL UNIVERSITY MEDICAL SCHOOL (AUSTRIA)
INTRODUCTION Persistent pulmonary hypertension of the newborn (PPHN) remains an important cause of mortality and morbidity in the term neonate. The severity of the illness and the outcome are related to the underlying cause. Therapies include inhaled nitric oxide (iNO), intravenous prostacyclin and sildenafil. We report the successful treatment of a neonate suffering from PPHN secondary to pulmonary hypertension caused by a skeletal dysplasia.
CASE REPORT The female infant was delivered at 37 weeks gestation with antenatal ultrasound findings a skeletal dysplasia. The diagnosis of spondyloepiphyseal dysplasia congenita was made based on the skeletal survey and clinical picture. She required significant ventilatory support and up to 100% oxygen because of PPHN. iNO resulted in a decrease in oxygen requirement to 80%. On day 36 oral sildenafil was commenced at a dose of 0.5mg/kg every 6 hours and increased over the next week to 2mg/kg every 6 hours. iNO was successfully weaned and ceased 4 days after commencing sildenafil. Within a week of commencing sildenafil the infant required less ventilation with a decrease in the oxygen requirement from 80% to 40%. She was successfully extubated to CPAP 4 weeks later. She has subsequently been discharged home on nasopharyngeal CPAP facilitated by home carers.
DISCUSSION PPHN occurs in 1-2/1000 live births PPHN is associated with significant mortality of up to 20%. Sildenafil is a specific PDE-5 inhibitor and is mostly known for its use in the treatment of erectile dysfunction. Preliminary findings suggest that sildenafil is effective in the long-term therapy of pulmonary hypertension and is particularly effective in reducing rebound hypertension after discontinuation of NO in patients with arterial pulmonary hypertension. Preliminary but limited data suggests that there might be a role for sildenafil in the treatment of PPHN. Randomised-controlled trials are required to determine its efficacy and safety. Background: In twin pregnancies complicated by twin-to-twin transfusion syndrome (TTTS) blood passes through unidirectional vascular shunts from the donor to the recipient twin. The donor twin consequently exhibits reduced growth velocity and oliguria. Proximal renal tubular dysgenesis (RTD) has been reported as a post mortem diagnosis in donor twins. We report a case of proximal RTD in a surviving donor twin.
DOUBLE TROUBLE: A CASE OF PROXIMAL TUBULAR DYSGENESIS IN A DONOR SURVIVOR OF TWIN-TO-TWIN TRANSFUSIN SYNDROME
Case Report: Monozygotic male twins were delivered at 30 weeks gestation for severe TTTS. The donor twin was initially hypotensive requiring inotropic support. He was oliguric for 12 days with a urine output of 0.1 ml/kg/hour. There was no acidaemia or significant hyperkalaemia. On day 20 his creatinine and urea peaked at 811 micromols/L and urea 39 mmols/L respectively. He developed hypertension and was managed with labetalol. By 30 days of life his urine output had normalised, although his creatinine remained elevated at 200 micromols/L. A renal biopsy performed at 12 weeks of age showed a paucity of proximal renal tubules consistent with proximal RTD.
Discussion: TTTS causes significant perinatal mortality and morbidity. In post mortem examination of donor twins with RTD a complete or near complete absence of proximal tubules and ischaemic glomeruli is has been described. It is postulated that RTD occurs as a consequence of chronic hypovolaemia resulting in hypoperfusion of the kidney and up-regulation of renin synthesis. Increased renin causes elevated levels of angiotensin II and subsequent vasoconstriction. Active apoptosis has also been described in RTD pathophysiology. Cardiovascular changes in survivors of TTTS are consistent with abnormalities of the renin-angiotensin system. The donor twin shows a protracted tendency towards vasoconstriction and hypertension that may lead to renal failure. Fetal renin gene expression may influence renal haemodynamics and amniotic fluid volumes in TTTS and thus may present an avenue for therapeutic interventions. Background: Examination of the placenta can yield valuable information that may be clinically significant for both mother and baby. In-utero infection may have serious long-term sequelae in the neonate. With the advent of intrapartum antibiotic prophylaxis for at risk pregnancies, the number of positive placental cultures may be decreased and significant infections may not be identified Aim: To determine whether placental culture rates are affected by antibiotic administration in the intrapartum period.
PLACENTAL CULTURES IN THE
Methods: A review of all placentas submitted for histopathology in 2003 was performed. The clinical records were reviewed for: gestation at delivery, duration of rupture of membranes prior to delivery, intrapartum antibiotic use, placental culture result and histological findings.
Results: 425 cases were identified. Of these 282 (66%) were cultured and 12 (4.3%) had positive culture results. Five (41.7%) of the women with positive placental cultures had received intrapartum antibiotics. All of these placentas had histopathological evidence of in-utero inflammation with chorioamnionitis and funisitis. Three of these cases were preterm deliveries (gestation Ͻ 37 weeks). Of the seven positive culture results without intrapartum antibiotics, 4 had evidence of in-utero inflammation on histological evaluation. 104/425 (24%) had histopathological evidence of in-utero inflammation, 51 (49%) had received intrapartum antibiotics. Bacteria cultured included Group B streptococcus, Bacteroides, Enterobacter cloacae, E. coli, Klebsiella, Morganella morganii and a coliform.
Conclusion: Despite a significant proportion of placentas noted to have evidence of in-utero inflammation, only a small proportion had positive placental cultures. The presence or absence of intrapartum antibiotics did not appear to significantly affect the number of positive culture results. Other possible reasons include a non microbiological cause of the inflammation or culturing techniques that cannot detect all possible causative organisms. A review of culture techniques is required to determine whether alternative methods may improve culture growth.
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PLACENTAL ASSESSMENT: SIMPLE TECHNIQUES TO ENHANCE BEST PRACTICE.
